Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
03/04/2018 | 15:06 | Alliance News | Motif Bio Submits New Iclaprim Drug Application, Gets FDA Fee Waiver | LSE:MTFB | Motif Bio Plc |
03/04/2018 | 08:01 | UK Regulatory | Motif Bio PLC Initiation of NDA Rolling Submission for Iclaprim | LSE:MTFB | Motif Bio Plc |
20/03/2018 | 12:08 | Alliance News | Motif Bio Delays Iclaprim New Drug Application, Shares Fall | LSE:MTFB | Motif Bio Plc |
20/03/2018 | 08:01 | UK Regulatory | Motif Bio PLC Motif Bio Update on NDA Submission for Iclaprim | LSE:MTFB | Motif Bio Plc |
19/03/2018 | 08:01 | RNS Non-Regulatory | Motif Bio PLC Motif Bio to present at upcoming conferences | LSE:MTFB | Motif Bio Plc |
13/03/2018 | 16:56 | UK Regulatory | Motif Bio PLC Change of Registered Office | LSE:MTFB | Motif Bio Plc |
07/03/2018 | 14:24 | Alliance News | Motif Bio Issues 178,571 Shares Following Warrants Exercise (ALLISS) | LSE:MTFB | Motif Bio Plc |
07/03/2018 | 13:29 | UK Regulatory | Motif Bio PLC Exercise of Warrants | LSE:MTFB | Motif Bio Plc |
01/03/2018 | 08:02 | UK Regulatory | Motif Bio PLC Grant of share options to senior management | LSE:MTFB | Motif Bio Plc |
21/02/2018 | 08:01 | RNS Non-Regulatory | Motif Bio PLC Motif Bio to Present Iclaprim Data at ECCMID 2018 | LSE:MTFB | Motif Bio Plc |
19/02/2018 | 14:28 | Alliance News | Motif Bio Nets GBP34,499 After Exercise Of Share Warrants (ALLISS) | LSE:MTFB | Motif Bio Plc |
02/02/2018 | 16:57 | Alliance News | Motif Bio Chief Financial Officer Robert Dickey To Resign | LSE:MTFB | Motif Bio Plc |
02/02/2018 | 16:00 | UK Regulatory | Motif Bio PLC Appointment of Interim Chief Financial Officer | LSE:MTFB | Motif Bio Plc |
29/01/2018 | 16:17 | PR Newswire (US) | Motif Bio PLC, Spero Therapeutics, Inc. and Vical Incorporated Join Antimicrobials Working Group | LSE:MTFB | Motif Bio Plc |
29/01/2018 | 13:07 | UK Regulatory | Motif Bio PLC Second Price Monitoring Extn | LSE:MTFB | Motif Bio Plc |
29/01/2018 | 13:02 | UK Regulatory | Motif Bio PLC Price Monitoring Extension | LSE:MTFB | Motif Bio Plc |
19/01/2018 | 08:00 | UK Regulatory | Motif Bio PLC Filing of U.S. Shelf Registration | LSE:MTFB | Motif Bio Plc |
16/01/2018 | 14:11 | Alliance News | Motif Bio Secures Funding To Advance Iclaprim Development | LSE:MTFB | Motif Bio Plc |
16/01/2018 | 08:00 | UK Regulatory | Motif Bio PLC Motif Bio Receives Award from CF Foundation | LSE:MTFB | Motif Bio Plc |
12/01/2018 | 16:12 | UK Regulatory | Motif Bio PLC Holding(s) in Company | LSE:MTFB | Motif Bio Plc |
08/01/2018 | 16:51 | Alliance News | Motif Bio Issues 471,602 Shares Following Warrants Exercise (ALLISS) | LSE:MTFB | Motif Bio Plc |
05/01/2018 | 08:00 | RNS Non-Regulatory | Motif Bio PLC Motif Bio to participate in panel discussion | LSE:MTFB | Motif Bio Plc |
22/12/2017 | 08:01 | UK Regulatory | Motif Bio PLC Notes statement from Amphion Innovations | LSE:MTFB | Motif Bio Plc |
21/12/2017 | 14:29 | Alliance News | Motif Bio Says Additional Iclaprim Study Results Published In Journal | LSE:MTFB | Motif Bio Plc |
21/12/2017 | 14:00 | RNS Non-Regulatory | Motif Bio PLC REVIVE-1 additional results published | LSE:MTFB | Motif Bio Plc |
14/12/2017 | 08:01 | RNS Non-Regulatory | Motif Bio PLC Filing of SEC Form F-3 | LSE:MTFB | Motif Bio Plc |
17/11/2017 | 11:08 | Alliance News | Motif Bio Gets GBP59,000 From Warrant Exercise (ALLISS) | LSE:MTFB | Motif Bio Plc |
17/11/2017 | 08:20 | Alliance News | *Motif Bio To Issue 183,031 Shares For GBP58,935 From Warrants Exercise (ALLISS) | LSE:MTFB | Motif Bio Plc |
15/11/2017 | 10:46 | Alliance News | Motif Bio Secures USD20 Million Debt Facility From Hercules Capital | LSE:MTFB | Motif Bio Plc |
15/11/2017 | 08:00 | UK Regulatory | Motif Bio PLC Secures up to US$20 million debt financing | LSE:MTFB | Motif Bio Plc |